Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Ray, U; Cinque, P; Gerevini, S; Longo, V; Lazzarin, A; Schippling, S; Martin, R; Buck, C B; Pastrana, D V (2015). JC polyomavirus mutants escape antibody-mediated neutralization. Science Translational Medicine, 7(306):306ra151.

Grint, D; Peters, L; Reekie, J; Soriano, V; Kirk, O; Knysz, B; Suetnov, O; Lazzarin, A; Ledergerber, B; Rockstroh, J K; Mocroft, A (2013). Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy. HIV Medicine, 14(6):370-378.

Hoen, B; Cooper, D A; Lampe, F C; Perrin, L; Clumeck, N; Phillips, A N; Goh, L-E; Lindback, S; Sereni, D; Gazzard, B; Montaner, J; Stellbrink, H-J; Lazzarin, A; Ponscarme, D; Staszewski, S; Mathiesen, L; Smith, D; Finlayson, R; Weber, R; Wegmann, L; Janossy, G; Kinloch-de Loes, S (2007). Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Clinical Infectious Diseases, 45(3):381-390.

Opravil, M; Hirschel, B; Lazzarin, A; Heald, A; Pechere, M; Ruttimann, S; Iten, A; von Overbeck, J; Oertle, D; Praz, G; Vuitton, D A; Mainini, F; Luthy, R (1995). Once-Weekly Administration of Dapsone/Pyrimethamine vs. Aerosolized Pentamidine as Combined Prophylaxis for Pneumocystis carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients. Clinical Infectious Diseases, 20(3):531-541.

Opravil, M; Pechere, M; Lazzarin, A; Heald, A; Ruttimann, S; Iten, A; Furrer, H; Oertle, D; Praz, G; Vuitton, D A; Hirschel, B; Luthy, R (1995). Dapsone/Pyrimethamine May Prevent Mycobacterial Disease in Immunosuppressed Patients Infected with the Human Immunodeficiency Virus. Clinical Infectious Diseases, 20(2):244-249.

This list was generated on Thu Jun 20 19:13:30 2019 CEST.